by Kirsten
Bibbins-Domingo, PhD, MD, MAS
Many of us do not routinely read the genetic literature, but
for those of us interested in health disparities, a study in this week’s NEJM and its implications are critically
important.
Tuesday, August 30, 2016
Monday, August 1, 2016
Science and Public Health on Trial
by Dean Schillinger, MD
Our purpose in writing this piece was to alert the
scientific, clinical, and public health communities about the outcome of the
landmark decision regarding warning
notices on advertisements for sugar sweetened beverages (SSBs) and explain its
legal underpinnings. We also wanted to show this as an exemplar of how industry-misappropriated scientific language and scientific methods to hijack science
and public health and obfuscate scientific truth and introduce controversy
regarding associations between their products (in this case SSBs) and health
harms (in this case obesity, diabetes, and tooth decay). Finally, we wanted to
highlight the importance of such policy efforts for improving the health of
at-risk populations, including children, ethnic minorities, and individuals with
limited health literacy.
Click below to read the full JAMA viewpoint:
Subscribe to:
Posts (Atom)